Vaccinex, Inc is a biotechnology business based in the US. Vaccinex shares (VCNX) are listed on the NASDAQ and all prices are listed in US Dollars. Vaccinex employs 39 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Vaccinex
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – VCNX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Vaccinex stock price (NASDAQ: VCNX)Use our graph to track the performance of VCNX stocks over time.
Vaccinex shares at a glance
|Latest market close||$2.34|
|52-week range||$1.63 - $7.20|
|50-day moving average||$2.60|
|200-day moving average||$2.77|
|Wall St. target price||$7.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.01|
Buy Vaccinex shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Vaccinex stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Vaccinex price performance over time
|1 week (2021-07-25)||N/A|
|1 month (2021-07-02)||-14.60%|
|3 months (2021-05-05)||-1.27%|
|6 months (2021-02-01)||N/A|
|1 year (2020-08-01)||N/A|
|2 years (2019-08-01)||N/A|
|3 years (2018-08-01)||N/A|
|5 years (2016-08-01)||N/A|
|Revenue TTM||$1.5 million|
|Gross profit TTM||$-20,926,000|
|Return on assets TTM||-96.35%|
|Return on equity TTM||-268.76%|
|Market capitalisation||$69.7 million|
TTM: trailing 12 months
Shorting Vaccinex shares
There are currently 830,358 Vaccinex shares held short by investors – that's known as Vaccinex's "short interest". This figure is 9.1% down from 913,296 last month.
There are a few different ways that this level of interest in shorting Vaccinex shares can be evaluated.
Vaccinex's "short interest ratio" (SIR)
Vaccinex's "short interest ratio" (SIR) is the quantity of Vaccinex shares currently shorted divided by the average quantity of Vaccinex shares traded daily (recently around 247130.35714286). Vaccinex's SIR currently stands at 3.36. In other words for every 100,000 Vaccinex shares traded daily on the market, roughly 3360 shares are currently held short.
However Vaccinex's short interest can also be evaluated against the total number of Vaccinex shares, or, against the total number of tradable Vaccinex shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Vaccinex's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Vaccinex shares in existence, roughly 30 shares are currently held short) or 0.0537% of the tradable shares (for every 100,000 tradable Vaccinex shares, roughly 54 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Vaccinex.
Find out more about how you can short Vaccinex stock.
Vaccinex share dividends
We're not expecting Vaccinex to pay a dividend over the next 12 months.
Vaccinex share price volatility
Over the last 12 months, Vaccinex's shares have ranged in value from as little as $1.63 up to $7.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Vaccinex's is 1.752. This would suggest that Vaccinex's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Vaccinex, Inc. , a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab, a humanized monoclonal antibody that is in Phase 1 and 2 clinical trials for the treatment of non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), Huntington's disease, Alzheimer's disease, osteosarcoma, and melanoma. The company is also developing VX5, a human antibody to CXCL13 that is in preclinical development for the treatment of MS and for other autoimmune disorders; and VX25, a bi-specific molecule based on natural killer T (NKT) vaccine platform for the therapeutic application of NKT cell stimulation for cancer immunotherapy. Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York.
Stocks similar to Vaccinex
Vaccinex in the news
A Look At Vaccinex's (NASDAQ:VCNX) Share Price Returns
Despite Lacking Profits Vaccinex (NASDAQ:VCNX) Seems To Be On Top Of Its Debt
Frequently asked questionsWhat percentage of Vaccinex is owned by insiders or institutions?
Currently 14.494% of Vaccinex shares are held by insiders and 36.266% by institutions. How many people work for Vaccinex?
Latest data suggests 39 work at Vaccinex. When does the fiscal year end for Vaccinex?
Vaccinex's fiscal year ends in December. Where is Vaccinex based?
Vaccinex's address is: 1895 Mount Hope Avenue, Rochester, NY, United States, 14620 What is Vaccinex's ISIN number?
Vaccinex's international securities identification number is: US9186401033 What is Vaccinex's CUSIP number?
Vaccinex's Committee on Uniform Securities Identification Procedures number is: 918640103
More guides on Finder
How to buy Chobani stock when it goes public
Everything we know about the Chobani IPO, plus information on how to buy in.
How to buy Stronghold Digital Mining (SDIG) stock when it goes public
Everything we know about the Stronghold Digital Mining IPO, plus information on how to buy in.
How to buy ROX Financial LP (ROXA) stock when it goes public
Everything we know about the ROX Financial LP IPO, plus information on how to buy in.
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
Ask an Expert